International Accreditation System for Interventional Oncology Services
Facility Updates

 

UOC Radiologia BT, Ospedale Civile Maggiore AOUI di Verona

Verona, Italy

Congratulations to Dr. Giovanni Puppini and the team at UOC Radiologia BT, Ospedale Civile Maggiore AOUI di Verona on achieving IASIOS accreditation.

This accomplishment reflects the team’s commitment to maintaining the highest standards of quality in interventional oncology and their dedication to delivering outstanding patient care. Through successful alignment with the CIRSE Standards of Quality Assurance, they have demonstrated excellence in clinical practice, robust governance, and collaborative multidisciplinary care.

IASIOS accreditation recognises their ongoing efforts to strengthen quality assurance, optimise treatment pathways, and provide safe, evidence-based, image-guided cancer therapies. We are delighted to celebrate this important milestone and congratulate Dr. Puppini and the entire team on their achievement.

Facility Updates

 

American Hospital Dubai

Dubai, United Arab Emirates

American Hospital Dubai has become an Enrolled Centre with IASIOS, marking the beginning of its accreditation journey and reinforcing its commitment to internationally recognised standards in interventional oncology.

This important milestone reflects the hospital’s dedication to quality assurance, patient safety, and multidisciplinary cancer care. IASIOS accreditation provides a robust framework for evaluation, peer review, and continuous quality improvement, supporting the delivery of safe, effective, and high-quality image-guided therapies.

We look forward to supporting the American Hospital Dubai team throughout their accreditation journey.

Facility Updates

 

St George Hospital

Sydney, Australia

St George ICU - Humanity, Harmony, Humility

Congratulations to Dr. Desai, Dr. Lodh, and the team at St. George Hospital on earning IASIOS accreditation.

This recognition underscores their dedication to upholding internationally recognised standards in interventional oncology and their commitment to continuous quality improvement. By aligning with the CIRSE Standards of Quality Assurance, the team has demonstrated excellence in clinical governance, multidisciplinary collaboration, and evidence-based practice.

Achieving IASIOS accreditation highlights their focus on patient safety, treatment efficacy, and structured care pathways, while reinforcing their position as a centre of excellence in minimally invasive, image-guided cancer therapies.

Facility Updates

 

Siriraj Center of Interventional Radiology

Bangkok, Thailand

Siriraj Center of Interventional Radiology has become an Enrolled Centre with IASIOS, initiating its journey toward accreditation and demonstrating its commitment to internationally recognised standards in interventional oncology.

This milestone highlights a strong emphasis on quality assurance, patient safety, and collaborative, multidisciplinary cancer care. IASIOS accreditation offers a comprehensive framework for assessment, peer review, and ongoing quality improvement, helping ensure the delivery of safe, reliable, and high-quality image-guided therapies.

We look forward to supporting the team throughout their accreditation process.

Facility Updates

 

Portuguese Institute of Oncology (IPO-Porto)

Porto, Portugal

Congratulations to Dr. Belarmino Gonçalves, Mr. Manuel Freitas, and the interventional oncology team at Portuguese Institute of Oncology (IPO-Porto) on achieving IASIOS accreditation.

This important milestone reflects a collective commitment to excellence in interventional oncology and to delivering care in line with internationally recognised quality standards. Through the successful implementation of the CIRSE Standards of Quality Assurance, the team has demonstrated its dedication to clinical excellence, multidisciplinary collaboration, and continuous quality improvement.

IASIOS accreditation recognises the team’s commitment to providing safe, effective, and patient-focused image-guided cancer therapies, while further strengthening quality assurance across their service.

We are delighted to celebrate this outstanding achievement and extend our sincere congratulations to Dr. Gonçalves, Mr. Freitas, and the entire team at IPO-Porto on this well-deserved success.

Facility Updates

 

Semmelweis University

Budapest, Hungary

Congratulations to Dr. Deák Pál Ákos and team at Semmelweis University in Budapest, Hungary on achieving IASIOS accreditation.

This significant accomplishment highlights their unwavering commitment to excellence and their leadership in advancing high-quality cancer care. By meeting the benchmarks set by the CIRSE Standards of Quality Assurance in Interventional Oncology, the team has demonstrated a clear dedication to delivering safe, effective, and patient-centered treatment.

This achievement not only reflects their expertise and collaboration but also reinforces their role as a leading centre for interventional oncology in the region.

Facility Updates

 

King Khalid Hospital

Najran, Saudi Arabia

We are pleased to welcome King Khalid Hospital as an IASIOS Enrolled Centre, reflecting its commitment to further developing interventional oncology within its clinical services.

By joining IASIOS, the team at King Khalid Hospital is taking an important step toward strengthening a structured, high-quality, and multidisciplinary approach to cancer care, with a clear focus on patient safety and continuous improvement.

We look forward to working closely with the team as they progress along the IASIOS pathway and contribute to the growing international community dedicated to excellence in interventional oncology.

Facility Updates

 

Evangelismos Hospital

Athens, Greece

With continued growth of the IASIOS network, we are pleased to welcome Evangelismos Hospital in Athens as a newly enrolled centre.

This step marks a meaningful investment in the future of interventional oncology at the institution, supporting the development of well-defined clinical pathways and a strong culture of quality assurance. By engaging with IASIOS, the team is actively working toward harmonising practices with international standards while fostering collaboration across specialties involved in cancer care.

Evangelismos Hospital now joins a diverse group of centres worldwide that are committed not only to maintaining high standards, but to continuously evolving and improving them.

IASIOS is glad to accompany the team on this journey and support their progress toward full accreditation.

Facility Updates

 

Radboud University Medical Center

Nijmegen, Netherlands

We are pleased to recognise a new achievement in accreditation: Radboud University Medical Center has attained IASIOS Accredited Centre status. This designation confirms that the interventional oncology service led by Dr. Mark Arntz meets established international criteria for clinical excellence, patient safety, and coordinated multidisciplinary cancer care.

IASIOS accreditation highlights a commitment to consistent, high-quality care delivery, grounded in validated clinical evidence and supported by ongoing evaluation and improvement. It also reflects the increasing role of image-guided, minimally invasive interventions as an integral part of contemporary oncology practice.

Congratulations to Dr. Mark Arntz and the entire team at Radboud University Medical Center for reaching this important milestone and for contributing to the advancement of interventional oncology standards.

IASIOS Council

Dr. Mark Arntz
Dr. Mark Arntz
IASIOS Council Member
(Radboud University Medical Center, Netherlands)
Facility Updates

 

University of Miami: Sylvester Comprehensive Cancer Center

Miami, USA

IASIOS is proud to welcome University of Miami: Sylvester Comprehensive Cancer Center as a new Enrolled Centre.

Joining IASIOS highlights the centre’s dedication to advancing excellence in interventional oncology through quality assurance, patient-centred care, and internationally recognised standards.

As part of the IASIOS community, the facility joins a global network of hospitals committed to strengthening cancer care through collaboration, continuous development, and best practice.

We are delighted to support the team as they begin their pathway toward IASIOS accreditation.